chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I experienced a fever going to sleep at 05/25/21 at 2300h. My temperature reading was 97 F. I woke up on 05/26/21 at approximately 0120h feeling the need to urinate and was very sweaty, hot and thirsty. I sat down to urinate, and I felt dizzy standing back up. I was feeling very thirsty so proceeded to walk to get some water. I fainted after walking about 10 feet. I regained consciousness, and I drank water and ingested an Advil with the help of my wife. I felt a lot better after drinking the water, but still had a mild throbbing headache. I went back to sleep, and the fever symptoms came and went which affected my sleep quality. I drank more water any time I woke up. I took 2 more Advil as well at one time waking up. I woke up around 1300h on 05/26/21 feeling a lot better and a little more well rested. My fever symptoms are gone, but I am still a little sensitive to cold and feeling a little weak.
body aches, fever - 5 days after shot. Patient seen on 9/29/21 and still with body aches, headache
This spontaneous report as received from a 75 year old female consumer with hypertension, allergy to naproxen, darunavir, amprenavir, sulfur, "analogous" and sulfonamide antibiotics allergy reporting on herself. On 08-MAR-2007, the patient was vaccinated with a dose of ZOSTAVAX (Lot # not reported) in the left arm. Concomitant therapies included CRESTOR and losartan potassium (manufacturer unknown). The consumer reported that on 03-SEP-2012, she experienced her first mild outbreak of shingles on right leg an on 24-MAR-2013, she experienced the second outbreak of shingles in the same area right leg back of the knee. The patient was treated with dimethicone, menthol (GOLD BOND MEDICATED BODY LOTION) to prevent itching and discomfort. At the time of the report, the patient's outcome was unknown. Additional information is not expected.
Vaginal yeast infection; This is a spontaneous report received from contactable consumer, the patient. A 54-year-old adult [non-pregnant] female received the first dose of BNT162B2 (solution for injection; batch/lot and expiry information not provided) as a single dose via an unspecified route in the left arm on 09Mar2021 at 15:45 (at 54-years-old), for COVID-19 immunization. Relevant medical history included neuropathy and depression. The patient denied any allergies to medications, food, or other products. Concomitant medications included gabapentin and bupropion. The patient was not diagnosed with COVID prior to the vaccine and was not pregnant at the time of vaccination. Additionally, the patient denied receiving any other vaccines within four weeks prior to this vaccine. On 09Mar2021 at 20:00 the patient began to experience a vaginal yeast infection. The patient reported that she went to the doctor or other healthcare professional office or clinic for the event. The patient has not been tested for COVID since receiving the vaccine. It was unknown if the event was treated. The outcome of the vaginal yeast infection was not recovered.   The lot number for the vaccine, BNT162b2, was provided as unknown and will be requested during follow up.
01/01/2022 History of present illness:  The patient presents with shortness of breath. 66 year old male who tested positive for COVID-19 on 12/27 presents with shortness of breath that also started on 12/27. Denies additional systemic symptoms.  The onset was 5  days ago.  The course/duration of symptoms is constant and worsening.  The Exacerbating factors is none.  The Relieving factors is none.  Risk factors consist of COVID-19.  Prior episodes: none.  Therapy today: none.  Associated symptoms: none.
12 Hours Post - Headache, Chills 24 Hours Post - Headache, Lymph Node Swelling in Booster Arm, Chest Ache  48-72 Hours Post - Chest Ache  Doctor prescribed 800mg ibuprofen regimen for suspected pericarditis.
developed a rash, that was hot to the touch and itchy and its covering the entire arm. I have fever of 100.9, body aches, chills, fatigue, vomiting, diarrhea. arm rash is horrible.
ED visit- Admission 7/23-7/24/13. Patient had his 2 mos wcv the morning of 7/23/13 at which time he was healthy with no recent history of sick symptoms including fever. He received his 2 mos immunizations. Mother drove to a store after the visit and when she stopped in the parking lot she noticed that patient was shaking and his eyes were rolling in the back of his head. He did not lose tone. Mother thinks the seizure like activity lasted for about 30 seconds. She call 911 and EMS came, but mother decided to observe and not got to the ED. 1 hr later she was at Grandma's house and he had the same episode that mother estimates lasted 60 seconds. They took him to hospital. He had no temperature on arrival. Per mother all blood and urine tests were negative. CT scan WNL. They kept him over night for observation and did an EEG in the morning which was normal.
pt recvd vax & pt stumbled out of bed, had a loss of sense of balance for 2 mins or so & had nausea the rest of the morning; pt did not receive treatment & had no further episodes;
Muscle soreness at site of injection (left deltoid). Muscle is continuing to remain sore and weak, feeling like it is strained or pulled.
Hair on legs & arms fell off.  Noticed DOS +4 days.  Complete hair loss on extremities DOS + 7.  Began to grow back DOS + 10.  At about 70% regrowth today.
Consistent fever of at least 101 degrees.  Body Aches (back & face), some light shaking, rapid heart beat.
Injection site bruised or rash; Night sweats; Injection site swelled up; Arm Soreness; Low grade fever; Injection site bruised or rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Injection site bruised or rash), NIGHT SWEATS (Night sweats), INJECTION SITE SWELLING (Injection site swelled up), MYALGIA (Arm Soreness) and PYREXIA (Low grade fever) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.     On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced VACCINATION SITE BRUISING (Injection site bruised or rash), NIGHT SWEATS (Night sweats), INJECTION SITE SWELLING (Injection site swelled up), MYALGIA (Arm Soreness), PYREXIA (Low grade fever) and VACCINATION SITE RASH (Injection site bruised or rash). At the time of the report, VACCINATION SITE BRUISING (Injection site bruised or rash), NIGHT SWEATS (Night sweats), INJECTION SITE SWELLING (Injection site swelled up), MYALGIA (Arm Soreness), PYREXIA (Low grade fever) and VACCINATION SITE RASH (Injection site bruised or rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was not provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up received on 14-JUL-2021 and contains no new significant information
Case number PHEH2015US019987 is an initial spontaneous report received from a consumer (patient's wife) on 05 OCT 2015. This report refers to a male patient whose age was not reported. Past medical history and concomitant medications were not reported. He was vaccinated with FLUVIRIN 2015/2016 (batch number: not reported) subcutaneously instead of intramuscularly on 05 OCT 2015. No adverse events were reported following the maladministration.
Vet reports difficulty lifting arms above head beginning 8 days after dose. Continued difficulty lifting above head and has pain that radiates to buttocks
At almost exactly 25 hours after the shot, I developed adverse events(as you say). I went for a six mile jog, took a hot shower, felt fine other than sore arm. Now I am running a fever, completely unable to get warm, and everything hurts. Somehow even the tops of my feet hurt?? Very bizarre. Feels like a bad flu.
Patient became short of breath. EMS states patient was wheezing upon their arrival. Nebulizer treatment and Benadryl given. Blood pressure 70/29. 400mcg of Epi given to patient via IV. Pt admitted to hospital and discharged on 4/21.
Sever headache  fatigue  sore throat  cough & congestion  & I was unable to work on Christmas eve
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 07Dec2021 as dose 4 (booster), single (Lot number: FH8027), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypothryoid" (unspecified if ongoing). Concomitant medication(s) included: ZOLOFT; ARMOUR THYROID; SYNTHROID; NALTREXONE; TOPIRAMATE; BUSPIRONE.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: Four days after stopping Paxlovid and being symptom-free and testing negative on a home antigen test; Positive, notes: mild symptoms returned and a home antigen test showed positive for COVID. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Antiviral treatment for COVID 19 were started from 16May2022 to 21May2022. Patient reported symptom-free and testing negative on a home antigen test, mild symptoms returned, and a home antigen test showed positive for COVID. Adverse events start date: 25May2022, Known allergies: No.
Dizziness, Myalgia, Fever, Diarrhea, NauseaVomiting, fatigue, dizziness, diarrhea, nausea and vimitting Narrative:
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Red, hard, 3" diameter circle below shoulder injection site in tricep.
While vacationing, went to the ER with slurred speech, diplopia, poor gait, tightness abdomen and chest. The pt was subsequently admitted to the hospital. Diagnosed with Guillian Barre syndrome, Miller Fisher variant.  Follow up on 01/17/2001: "Final diagnosis: Guillain-Barre Syndrome, diagnosis was made by neurologist.Patient had previous influenza vaccinations."  Follow up on 07/06/2001: "No acute illnesses prior to onset of GBS.  Immunizations received for influenza was 97 or 98 and 10/1999.  Final diagnosis was GBS.
Pt. was being treated for a second degree burn and was given an Adult Td vaccination in the left deltoid.  He reported at his next follow up appointment that about 4-6 hours after his initial visit he developed weakness in the right side of his face which has persisted--4 days.  He indeed has findings consistent with right sided facial weakness (Bell's Palsy).
First, I received a few bumps on the left side of my neck that then spread all across the front of my neck. A couple of days later I noticed a rash forming on my legs. The next day I noticed a rash forming on my stomach. It has spread to my back, chest, and arms. The worst part of the rash is on my stomach. The initial rash on my neck faded, but my stomach still has a rash and is sometimes itchy. The bumps are continuning to spread. I have not visited a medical professional because it doesn?t seem urgent or life threatening.
Vaccine expired on 03-Oct-2021 and then stored in refrigerator on 03-Nov-2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 03-Oct-2021 and then stored in refrigerator on 03-Nov-2021) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 03-Oct-2021 and then stored in refrigerator on 03-Nov-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 03-Oct-2021 and then stored in refrigerator on 03-Nov-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment medication was not reported. No adverse event was reported. There was not any temperature excursion. Date placed in refrigerator on 03-Nov-2021.
sore arm (48 hours), loss of appetite (12 hours), fatigue (24 hours), chills (18 hours)
About 11 hours after the injection, I began to feel cold despite being in a warm room. Within 3 hours, I developed chills and rigors. I woke up repeatedly during the night with generalized body aches, fevers, excessive sweating and severe headache. It is about 36 hours post-injection and I still have severe headache, malaise, body aches, flushing, and lightheadedness.
Headache, Myalgia, Fever, NauseaVomiting, FATIGUE, Narrative:
CHEST PAIN,  HEAVINESS IN CHEST, JAW PAIN -- TOOK ASPIRIN (4) ,  STILL SLIGHT DISCOMFORT RASH- FACE NECK UPPER TORSO,  UPPER TORSO BUMPS - STILL HAS  I ADVISED HER TO SEE A DOCTOR
Equipment malfunction on first attempt of dose. Administering pharmacist believes greater than half of the dose was lost on external portion of arm/skin between syringe and needle. Vaccine was re-administered with full dose. Patient reported feeling very sick after administration of dose, report included general overall sickness, use of oxygen required, returned to lower home elevation and extreme dizziness.
Patient complained of dizziness then stopped verbalizing.  Vital signs: 130/90 P-88.  After 10 minutes pulse became thready and patient exhibited seizure symptoms.  Breathing was stable.  RN administered epi IM.  Patient transported to Hospital by ambulance.  Patient discharged from ER by 7:30 pm that evening.  No further issues disclosed by school administration.
Red, raised 2 inch x 1 inch area surrounding injection area. C/o puritis. Mild edema noted, mild discomfort to touch. Referred to physician. Patient took Claritin on 1/15/13. Patient called to report on 1/16/13 that her arm had increased redness, puritis, edema and pain. Physician scheduled to see patient and on 1/17/13, patient was prescribed methylprednisolone 4mg dose pack disp 21 tabs. On 1/22/13 at 0930 patient notified the clinic that all symptoms of the reaction were resolved with the exception of a darkish mark to the left arm where the injection was given.
Fever (101.7 tympanic), headache, joint pain (hip, knees, ankles, shoulder), nausea, shaky.
Welts fr chin level to thigh: severe itching (hives) bodily including eyes, nose, mouth, tongue; 3wks fr 2nd dose heptavac rec'd Epinephrine x 2;
Patient states his arm hurts where the shot was given. States it feels like he just got the shot but it has been 2 months.
A report was received from a health care professional on 2/24/04 concerning up to 8 vaccinees under 4 years of age and of unknown gender who inadvertently received a dose of Fluvirin vaccine on an unreported day in December 2003. On an unspecified day in December 2003, up to 8 vaccinees were inadvertently administered Fluvirin. The outcome of the event was not reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 3/22/04: Further information was received from a health care professional indicating that the vaccinee was a 40 month old male who inadvertently received 0.5ml Fluvirin on 12/24/03. No adverse events were reported at the time of the event. No follow up pending. All information received.
Aches; Chills; Nausea; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches), CHILLS (Chills), NAUSEA (Nausea) and PYREXIA (Low grade fever) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 08-Mar-2021, the patient experienced PAIN (Aches), CHILLS (Chills), NAUSEA (Nausea) and PYREXIA (Low grade fever). On 08-Mar-2021, PYREXIA (Low grade fever) had resolved. At the time of the report, PAIN (Aches), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported. No Treatments were reported.
WIFE CAME IN 5 DAYS AFTER PATIENT RECEIVED VACCINE AND REPORTED THE NEXT DAY PATIENT  WAS ADMITTED TO HOSPITAL WITH A VERY VERY HIGH BLOOD SUGAR (WIFE SAID 1500?) AND IS ON RESPIRATOR. PATIENT'S ENDOCRINOLOGIST STATED PATIENT SHOULD OF NEVER GOTTEN BOTH VACCINES AT THE SAME TIME
Started as small lump around the site of injection, has grown in size for no reason. No pain associated. 7/9/14 - pt came back and now has a bruise on area where lump is. Appeared for "no reason".
This case was reported by a pharmacist via call center representative and described the occurrence of injection site rash in a 68-year-old female patient who received SHINGRIX (batch number 539A2, expiry date 30th March 2020). On 2nd April 2018 10:30, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 2nd April 2018, less than a day after receiving SHINGRIX, the patient experienced throbbing pain, injection site warmth, allergic reaction, fever and muscle pain. In April 2018, the patient experienced injection site rash. On an unknown date, the outcome of the injection site rash was recovering/resolving and the outcome of the throbbing pain, injection site warmth, allergic reaction, fever and muscle pain were unknown. The reporter considered the injection site rash, throbbing pain, injection site warmth, allergic reaction, fever and muscle pain to be related to SHINGRIX. Additional details were provided as follows: By the evening, on the day of vaccination, the patient felt fever coming on, experienced muscle pain and the injection site was radiating heat and throbbing pain. The patient developed rash below the injection site about 3 to 4 inches in diameter. The patient did visit her doctor. On 5th April 2018, the pharmacist was last spoken to the patient and at that time, the rash had faded slightly. The pharmacist stated that as per nurse practitioner, the patient might have experienced an allergic reaction to SHINGRIX. The reporter was transferred to medical information for assistance in determining if patient should receive the 2nd dose.
body ache; headache; This is a spontaneous report received from contactable reporter(s) (Other HCP) for a Pfizer sponsored program.  A 56 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 56 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Pain" (unspecified if ongoing), notes: pre-existing pain has subsided, mobility is better and no longer, taking gabapentin; "Neurological Itching" (unspecified if ongoing); "rheumatoid arthritis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "recovered", described as "body ache"; HEADACHE (non-serious), outcome "recovered", described as "headache".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A man reported his child was vaxed & 1 to 2 days following vax pt exp hives, gen urticaria, edema, joint pain, diff breathing;pt was unable to walk & was taken to ER;tx DPH, Epi, steroids & cortisone & given prescription for pred;
Fever of 101.7, chills, muscle aches, diarrhea, rash, fatigue.
Hard lump (golf ball size) to right of injection site, accompanied by circle red patch about 2" in diameter. Reporting this because I was the only one in our group that I know had this reaction.  Pain is minimal, not more than expected but the readness and hard lump is what is unusual. I've travelled abroad and had a variety of vaccines.  This is the first reaction of this type.  Redness  and hardness is subsiding by day 4 and now my arm just really itches in that spot.  Reporting not because of concern but just to help with research.
After getting the first dose of the Shingles shot on Sunday, September 1, 2019,  I woke up on Thursday, September 5, 2019 with blisters.  I went to my dr on Friday, September 6, 2019 and he said I had shingles.  They appeared on the left side of my stomach.   Since Thursday, my blood pressure has been erratic, I've been having night sweats and an overall queasy feeling, nervousness.  Note:  my husband woke up this morning with a blister on the front of his stomach, he got his shot the same date and time I did.
Narrative:  Patient received first Moderna COVID-19 vaccine 1/15/21 and  second dose 2/12/21. Patient presented 2/16/21 with chief complaint of: Generalized, red, itchy rash that started (2/15). Patient reports that he  noticed itchy rash on bilateral forearms initially yesterday. He applied OTC Cortisone on his bilateral forearms with some relief. He started having itchy rash  on his back, groin and bilateral thighs today. He has not taken any Benadryl. He  states that aside from the itchy rash, he has not had any other adverse reactions. He  denies wheezing, SOB, chest pain, cough or sore throat. No swelling of tongue or  lips. Was prescribed outpatient orders for diphenhydramine, famotidine, and triamcinolone cream. Discharged home from outpatient clinic.